相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists
Timothy J. Henrich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug
Opass Putcharoen et al.
JOURNAL OF VIROLOGY (2012)
Mapping and Characterization of Vicriviroc Resistance Mutations From HIV-1 Isolated from Treatment-Experienced Subjects Enrolled in a Phase II Study (VICTOR-E1)
Paul M. McNicholas et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism
Michael Roche et al.
JOURNAL OF VIROLOGY (2011)
Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc
Pierre Delobel et al.
AIDS (2010)
Evolution of CCR5 Antagonist Resistance in an HIV-1 Subtype C Clinical Isolate
Timothy J. Henrich et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Characterization of Emergent HIV Resistance in Treatment-Naive Subjects Enrolled in a Vicriviroc Phase 2 Trial
Paul McNicholas et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates
Nina H. Lin et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5
John C. Tilton et al.
JOURNAL OF VIROLOGY (2010)
HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells
Jennifer M. Pfaff et al.
JOURNAL OF VIROLOGY (2010)
Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5
Robert A. Ogert et al.
VIROLOGY (2010)
HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes
Kosuke Miyauchi et al.
CELL (2009)
Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment
Christina M. R. Kitchen et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2009)
In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine
Roger Paredes et al.
JOURNAL OF VIROLOGY (2009)
HR-2 Mutations in Human Immunodeficiency Virus Type 1 gp41 Restore Fusion Kinetics Delayed by HR-1 Mutations That Cause Clinical Resistance to Enfuvirtide
Neelanjana Ray et al.
JOURNAL OF VIROLOGY (2009)
Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo
Athe M. N. Tsibris et al.
PLOS ONE (2009)
Elite Suppressor-Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics
Kara G. Lassen et al.
PLOS PATHOGENS (2009)
Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response
Ryan M. Troyer et al.
PLOS PATHOGENS (2009)
Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
Reem Berro et al.
PLOS PATHOGENS (2009)
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection
Jeffrey A. Anderson et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Viral dynamics and in vivo fitness of HIV-1 in the presence and absence of enfuvirtide
Vincent Marconi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject
Athe M. N. Tsibris et al.
JOURNAL OF VIROLOGY (2008)
Mechanistic studies of a T20-dependent human immunodeficiency virus type 1 variant
Chris Baldwin et al.
JOURNAL OF VIROLOGY (2008)
Subgroup analyses of Maraviroc in previously treated R5 HIV-1 infection
Gerd Faetkenheuer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Maraviroc for previously treated patients with R5 HIV-1 infection
Roy M. Gulick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120
Robert A. Ogert et al.
VIROLOGY (2008)
Clinical significance of human immunodeficiency virus type 1 replication fitness
Carrie Dykes et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-infected, treatment experienced patients: AIDS clinical trials group 5211
Roy M. Gulick et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
High throughput functional analysis of HIV-1 env genes without cloning
Jennifer L. Kirchherr et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss
Cleo G. Anastassopoulou et al.
PLOS PATHOGENS (2007)
Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors
Neelanjana Ray et al.
JOURNAL OF VIROLOGY (2007)
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry
Mike Westby et al.
JOURNAL OF VIROLOGY (2007)
Continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced HIV type 1 disease
Christina M. R. Kitchen et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients
Beatrice Labrosse et al.
JOURNAL OF VIROLOGY (2006)
Emergence of CXCR4-Using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-Infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir
M Westby et al.
JOURNAL OF VIROLOGY (2006)
Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay
HL Wu et al.
JOURNAL OF VIROLOGY (2006)
Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations
C Pastore et al.
JOURNAL OF VIROLOGY (2006)
Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection
SG Deeks et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Genome sequencing in microfabricated high-density picolitre reactors
M Margulies et al.
NATURE (2005)
Quasispecies theory in the context of population genetics
CO Wilke
BMC EVOLUTIONARY BIOLOGY (2005)
Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry
AJ Marozsan et al.
JOURNAL OF VIROLOGY (2005)
Enfuvirtide resistance mutations: Impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization
JD Reeves et al.
JOURNAL OF VIROLOGY (2005)
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41
L Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20)
J Lu et al.
JOURNAL OF VIROLOGY (2004)
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor
SE Kuhmann et al.
JOURNAL OF VIROLOGY (2004)
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects
R Swanstrom et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor
CE Baldwin et al.
JOURNAL OF VIROLOGY (2004)
Role of the human immunodeficiency virus type 1 envelope gene in viral fitness
HR Rangel et al.
JOURNAL OF VIROLOGY (2003)
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
M Cavrois et al.
NATURE BIOTECHNOLOGY (2002)
Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure
GH Kijak et al.
JOURNAL OF VIROLOGY (2002)
Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations
HL Devereux et al.
JOURNAL OF MEDICAL VIROLOGY (2001)
MRBAYES: Bayesian inference of phylogenetic trees
JP Huelsenbeck et al.
BIOINFORMATICS (2001)
Estimating relative fitness in viral competition experiments
AFM Marée et al.
JOURNAL OF VIROLOGY (2000)
分享论文
